Filing metadata

Accession number
0000899243-22-034414
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Oct 28, 2022
Reporting period
Oct 26, 2022
Description
Insider transaction

Explore SEC Filings Hub